These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 11995446
21. Bcl-2 positivity in B and C hepatitis and hepatocellular carcinomas. Yildiz L, Baris S, Aydin O, Kefeli M, Kandemir B. Hepatogastroenterology; 2008; 55(88):2207-10. PubMed ID: 19260506 [Abstract] [Full Text] [Related]
22. Large cell change of hepatocytes in chronic viral hepatitis represents a senescent-related lesion. Ikeda H, Sasaki M, Sato Y, Harada K, Zen Y, Mitsui T, Nakanuma Y. Hum Pathol; 2009 Dec; 40(12):1774-82. PubMed ID: 19733384 [Abstract] [Full Text] [Related]
23. Infection of a human hepatoma cell line by hepatitis B virus. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, Guyomard C, Lucas J, Trepo C, Guguen-Guillouzo C. Proc Natl Acad Sci U S A; 2002 Nov 26; 99(24):15655-60. PubMed ID: 12432097 [Abstract] [Full Text] [Related]
24. [Relationship between death receptor 5 and apoptosis in hepatocellular carcinoma]. Zhu RX, Lin JS, Song YH, Li PY, Tao LW. Zhonghua Zhong Liu Za Zhi; 2006 Apr 26; 28(4):261-4. PubMed ID: 16875623 [Abstract] [Full Text] [Related]
25. Investigation in liver tissues and cell lines of the transcription of 13 genes mapping to the 16q24 region that are frequently deleted in hepatocellular carcinoma. Riou P, Saffroy R, Comoy J, Gross-Goupil M, Thiéry JP, Emile JF, Azoulay D, Piatier-Tonneau D, Lemoine A, Debuire B. Clin Cancer Res; 2002 Oct 26; 8(10):3178-86. PubMed ID: 12374686 [Abstract] [Full Text] [Related]
26. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1994 Feb 26; 430():1-280. PubMed ID: 12616301 [Abstract] [Full Text] [Related]
27. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver. Masaki T, Tokuda M, Yoshida S, Nakai S, Morishita A, Uchida N, Funaki T, Kita Y, Funakoshi F, Nonomura T, Himoto T, Deguchi A, Kimura Y, Izuishi K, Wakabayashi H, Usuki H, Yoshiji H, Watanabe S, Kurokohchi K, Kuriyama S. Int J Oncol; 2005 Mar 26; 26(3):661-71. PubMed ID: 15703821 [Abstract] [Full Text] [Related]
28. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP. Clin Gastroenterol Hepatol; 2007 Aug 26; 5(8):938-45, 945.e1-4. PubMed ID: 17509946 [Abstract] [Full Text] [Related]
29. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus]. Yan SN, Deng B, Gong ZJ. Ai Zheng; 2003 May 26; 22(5):504-7. PubMed ID: 12753712 [Abstract] [Full Text] [Related]
30. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H, Taniguchi H. Hepatology; 2006 Jul 26; 44(1):240-51. PubMed ID: 16799977 [Abstract] [Full Text] [Related]
31. [Damage effects of peroxynitrite on different hepatocyte lines]. Wang X, Yu Y, Li H, Xu S. Wei Sheng Yan Jiu; 2004 May 26; 33(3):261-3. PubMed ID: 15211786 [Abstract] [Full Text] [Related]
32. Expression of hepatitis C virus core protein impairs DNA repair in human hepatoma cells. van Pelt JF, Severi T, Crabbé T, Eetveldt AV, Verslype C, Roskams T, Fevery J. Cancer Lett; 2004 Jun 25; 209(2):197-205. PubMed ID: 15159022 [Abstract] [Full Text] [Related]
33. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma. El-Bassiouni A, Nosseir M, Zoheiry M, El-Ahwany E, Ghali A, El-Bassiouni N. APMIS; 2006 Jun 25; 114(6):420-7. PubMed ID: 16856963 [Abstract] [Full Text] [Related]